Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression
Mathieu Nollet, Philippe Gaillard, Frédéric Minier, et al.
Neuropharmacology (2011) Vol. 61, Iss. 1-2, pp. 336-346
Closed Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

REM sleep dysregulation in depression: State of the art
Laura Palagini, Chiara Baglioni, Antonio Ciapparelli, et al.
Sleep Medicine Reviews (2013) Vol. 17, Iss. 5, pp. 377-390
Closed Access | Times Cited: 428
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Tobias Atkin, Stefano Comai, Gabriella Gobbi
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 197-245
Open Access | Times Cited: 306
Models of Depression: Unpredictable Chronic Mild Stress in Mice
Mathieu Nollet, Anne‐Marie Le Guisquet, Catherine Belzung
Current Protocols in Pharmacology (2013) Vol. 61, Iss. 1
Closed Access | Times Cited: 205
A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
Rai Khalid Farooq, Elsa Isingrini, Arnaud Tanti, et al.
Behavioural Brain Research (2012) Vol. 231, Iss. 1, pp. 130-137
Closed Access | Times Cited: 161
Neurogenesis-Independent Antidepressant-Like Effects on Behavior and Stress Axis Response of a Dual Orexin Receptor Antagonist in a Rodent Model of Depression
Mathieu Nollet, Philippe Gaillard, Arnaud Tanti, et al.
Neuropsychopharmacology (2012) Vol. 37, Iss. 10, pp. 2210-2221
Open Access | Times Cited: 132
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 114
The hypocretin (orexin) system: from a neural circuitry perspective
Shi‐Bin Li, Luı́s de Lecea
Neuropharmacology (2020) Vol. 167, pp. 107993-107993
Closed Access | Times Cited: 111
Ocular Surface Extracellular DNA and Nuclease Activity Imbalance: A New Paradigm for Inflammation in Dry Eye Disease
Snehal Sonawane, Vishakha Khanolkar, Abed Namavari, et al.
Investigative Ophthalmology & Visual Science (2012) Vol. 53, Iss. 13, pp. 8253-8253
Open Access | Times Cited: 109
Orexins and stress
Laura A. Grafe, Seema Bhatnagar
Frontiers in Neuroendocrinology (2018) Vol. 51, pp. 132-145
Open Access | Times Cited: 106
Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders
Morgan H. James, Erin J. Campbell, Christopher V. Dayas
Current topics in behavioral neurosciences (2017), pp. 197-219
Open Access | Times Cited: 102
The role of the orexin system in stress response
Derya Sargin
Neuropharmacology (2018) Vol. 154, pp. 68-78
Closed Access | Times Cited: 90
Anhedonia in depression symptomatology: Appetite dysregulation and defective brain reward processing
Roberto Coccurello
Behavioural Brain Research (2019) Vol. 372, pp. 112041-112041
Closed Access | Times Cited: 77
Models of Depression: Unpredictable Chronic Mild Stress in Mice
Mathieu Nollet
Current Protocols (2021) Vol. 1, Iss. 8
Open Access | Times Cited: 58
Understanding the Biological Relationship between Migraine and Depression
Adrián Viudez‐Martínez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 163-163
Open Access | Times Cited: 9
Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats
Elizabeth A. Lungwitz, Andrei I. Molosh, Philip L. Johnson, et al.
Physiology & Behavior (2012) Vol. 107, Iss. 5, pp. 726-732
Open Access | Times Cited: 103
The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamus
Christine Nocjar, J. Zhang, Pingfu Feng, et al.
Neuroscience (2012) Vol. 218, pp. 138-153
Closed Access | Times Cited: 98
Faster, better, stronger: Towards new antidepressant therapeutic strategies
Olivia F. O’Leary, Timothy G. Dinan, John F. Cryan
European Journal of Pharmacology (2014) Vol. 753, pp. 32-50
Closed Access | Times Cited: 93
Changes in orexin (hypocretin) neuronal expression with normal aging in the human hypothalamus
Nicholas J. Hunt, Michael Rodriguez, Karen A. Waters, et al.
Neurobiology of Aging (2014) Vol. 36, Iss. 1, pp. 292-300
Closed Access | Times Cited: 86
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
Jiann Wei Yeoh, Erin J. Campbell, Morgan H. James, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 86
Metabolic regulation of lateral hypothalamic glucose-inhibited orexin neurons may influence midbrain reward neurocircuitry
Zhenyu Sheng, Ammy M. Santiago, Mark Thomas, et al.
Molecular and Cellular Neuroscience (2014) Vol. 62, pp. 30-41
Open Access | Times Cited: 84
Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention
Mathieu Nollet, Samuel Leman
CNS Drugs (2013) Vol. 27, Iss. 6, pp. 411-422
Closed Access | Times Cited: 80
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
The brain orexin system and almorexant in fear-conditioned startle reactions in the rat
Michel A. Steiner, Hugues Lecourt, François Jenck
Psychopharmacology (2012) Vol. 223, Iss. 4, pp. 465-475
Closed Access | Times Cited: 78
Page 1 - Next Page

Scroll to top